The main functions and therapeutic effects of obeticholic acid tablets

Obeticholic acid(Obeticholic acid) is a new drug for the treatment of chronic liver diseases and belongs to the farnesoid X receptor (FXR) agonist class. It activates the FXR receptor in the nucleus of liver cells and regulates the synthesis and transport of bile acids, thereby significantly improving the cholestasis state. This mechanism is particularly useful in the treatment of primary biliary cholangitis (PBC), an autoimmune disease characterized by chronic inflammation of the intrahepatic bile ducts and bile retention. For patients who have insufficient response or intolerance to traditional treatments such as ursodeoxycholic acid (UDCA), obeticholic acid provides a new treatment option and is considered the second-line drug after UDCA treatment failure.

The main effects of this drug are to reduce liver enzyme levels, improve bile acid metabolism and delay the progression of liver fibrosis. Its role is not limited to controlling liver function indicators, but may also delay the progression of the disease to the end-stage stage of cirrhosis or even liver failure. Foreign studies have shown that obeticholic acid has good biochemical index improvement effects and long-term liver protection for patients who have poor response to existing therapies. In addition, studies are also exploring its potential in non-alcoholic steatohepatitis (NASH), although this indication is still in the investigational stage.

Another important feature of obeticholic acid is its strong targeting, which can significantly reduce liver inflammation and bile acid toxicity without interfering with other key metabolic pathways. Although some patients may experience side effects such as mild itching in the early stages of treatment, the overall tolerance is good. As the drug has been approved for marketing in many countries, its clinical experience has gradually enriched, and doctors can flexibly adjust treatment plans according to the specific conditions of patients. In short, obeticholic acid, as a FXR agonist with a unique mechanism, provides a precise and effective treatment approach for the treatment of cholestatic liver disease and is one of the most promising new drugs in this field.

Reference materials:https://en.wikipedia.org/wiki/Obeticholic_acid